Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival

被引:106
|
作者
Koukourakis, MI [1 ]
Giatromanolaki, A
Kakolyris, S
O'Byrne, KJ
Apostolikas, N
Skarlatos, J
Gatter, KC
Harris, AL
机构
[1] Univ Hosp Irakl, Dept Radiotherapy Oncol, Iraklion 71110, Greece
[2] Univ Hosp Irakl, St Nikolas Histopathol Unit, Iraklion 71110, Greece
[3] Oxford Radcliffe Hosp, Dept Cellular Sci, Oxford OX3 7LJ, England
[4] Oxford Radcliffe Hosp, Dept ICRF, Med Oncol Unit, Oxford OX3 7LJ, England
[5] Hellen Canc Inst, Dept Radiat Oncol, Athens, Greece
[6] Hellen Canc Inst, Dept Histopathol, Athens, Greece
关键词
PD-ECGF; thymidine phosphorylase fibroblast; macrophage; lung cancer;
D O I
10.1038/bjc.1998.280
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Angiogenesis is recognized as an important step in tumour pathogenesis that is related to invasion and metastatic spread and which consequently results in poor clinical outcome. In this study, we have examined the role of tumour stroma-activated fibroblasts and macrophage infiltration in the development of the angiogenic and metastatic phenotype in non-small-cell lung cancer (NSCLC). A total of 141 cases of early stage I-Il NSCLC treated with surgery alone were analysed. The JC-70 (anti-CD31) MAb was used for the assessment of vascular grade. The P-GF.44C MAb was used to assess thymidine phosphorylase (TP) reactivity in cancer cells, stromal fibroblasts and macrophages, Cancer cell TP overexpression related to high vascular grade and to advanced T stage (P = 0.0004 and P = 0.02). Expression of TP in stromal fibroblasts also correlated with high angiogenesis (P = 0.01), but was independent of cancer cell expression. Fibroblast TP overexpression was related to abundant stroma (P=0.003), suggesting that TP may be a marker of active stroma, Moreover, intense macrophage infiltration was associated with fibroblast TP reactivity, regardless of the amount of stroma, suggesting that macrophages may be a major contributor to TP expression in stroma. Survival analysis showed that cancer cell TP overexpression was related to poor prognosis (P = 0.005). Although stroma TP is related to angiogenesis, in the low vascular grade group it defined a group of patients with better prognosis (P = 0.02). It may be that fibroblast TP reactivity is an indirect marker of tumour infiltration by functional macrophages, which have an anti-tumour effect, We conclude that stromal macrophage and fibroblast TP reactivity may have an important role in non-small-cell lung cancer behaviour. Understanding the role of stromal fibroblasts and inflammatory cells and their interaction with oncoprotein expression is essential for the elucidation of lung cancer pathogenesis.
引用
收藏
页码:1696 / 1703
页数:8
相关论文
共 50 条
  • [11] Non-small-cell lung cancer
    不详
    NATURE REVIEWS DISEASE PRIMERS, 2024, 10 (01):
  • [13] Non-small-cell lung cancer
    Goldstraw, Peter
    Ball, David
    Jett, James R.
    Le Chevalier, Thierry
    Lim, Eric
    Nicholson, Andrew G.
    Shepherd, Frances A.
    LANCET, 2011, 378 (9804): : 1727 - 1740
  • [14] Low Thymidylate Synthase, Thymidine Phosphorylase, and Dihydropyrimidine Dehydrogenase mRNA Expression Correlate With Prolonged Survival in Resected Non-Small-Cell Lung Cancer
    Grimminger, Peter P.
    Schneider, Paul M.
    Metzger, Ralf
    Vallboehmer, Daniel
    Hoelscher, Arnulf H.
    Danenberg, Peter V.
    Brabender, Jan
    CLINICAL LUNG CANCER, 2010, 11 (05) : 328 - 334
  • [15] Thymidine phosphorylase expression in tumour cells and tumour response to capecitabine plus docetaxel chemotherapy in non-small cell lung cancer
    Han, JY
    Hong, EK
    Lee, SY
    Yoon, SM
    Lee, DH
    Lee, JS
    JOURNAL OF CLINICAL PATHOLOGY, 2005, 58 (06) : 650 - 654
  • [16] Amrubicin for non-small-cell lung cancer and small-cell lung cancer
    Kurata, Takayasu
    Okamoto, Isamu
    Tamura, Kenji
    Fukuoka, Masahiro
    INVESTIGATIONAL NEW DRUGS, 2007, 25 (05) : 499 - 504
  • [17] Amrubicin for non-small-cell lung cancer and small-cell lung cancer
    Takayasu Kurata
    Isamu Okamoto
    Kenji Tamura
    Masahiro Fukuoka
    Investigational New Drugs, 2007, 25 : 499 - 504
  • [18] Clinical Utility of Circulating Tumour Cell Detection in Non-Small-Cell Lung Cancer
    Alberto Fusi
    Robert Metcalf
    Matthew Krebs
    Caroline Dive
    Fiona Blackhall
    Current Treatment Options in Oncology, 2013, 14 : 610 - 622
  • [19] IMPACT OF NEOADJUVANT RADIATION ON SURVIVAL IN STAGE III NON-SMALL-CELL LUNG CANCER
    Koshy, Matthew
    Goloubeva, Olga
    Suntharalingam, Mohan
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 79 (05): : 1388 - 1394
  • [20] Clinical Utility of Circulating Tumour Cell Detection in Non-Small-Cell Lung Cancer
    Fusi, Alberto
    Metcalf, Robert
    Krebs, Matthew
    Dive, Caroline
    Blackhall, Fiona
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2013, 14 (04) : 610 - 622